SMITHS FALLS, ON, Oct. 30, 2019 /CNW/ - Spectrum Therapeutics, the
medical division of Canopy Growth Corporation ("Canopy Growth")
(TSX: WEED) (NYSE: CGC) is pleased to announce that it has
partnered with Tree of Knowledge International Corp. ("Tree of
Knowledge") (CSE: TOKI) (OTC: TOKIF) to provide education and
support for patients and their healthcare professionals working
within the Tree of Knowledge healthcare network across
Canada.
As part of the two year agreement, Spectrum Therapeutics will
collaborate with Tree of Knowledge's partner clinic, Jack Nathan
Health, to launch several e-learning modules on its online
education platform for healthcare professionals practicing in
Jack Nathan clinics. In addition,
Spectrum Therapeutics will host live webinars presented by leading
Canadian experts on medical cannabis including: Dr. Kevin Rod, director of Toronto Poly Clinic
multidisciplinary pain management clinics and Tree of Knowledge's
Chief Medical Officer; Canopy Growth's Chief Medical Officer, Dr.
Mark Ware and its Director of Global
Medical Services, Dr. Danial
Schecter. Topics that will be covered include an overview of
medical cannabis and best practices for prescribing and dosing as
well as chronic pain management and opioid reduction.
Through its partnership with Jack Nathan Health, Tree of
Knowledge will offer Chronic Pain Management and Medical Cannabis
education programs in Jack Nathan
clinics, which are located in 74 Walmart stores across six Canadian
provinces and, on a combined basis, have more than 1.5 million
patient visits annually. Jack Nathan Health also has six clinic
locations in Mexico which are
ideally positioned to support the opening of the Mexican medical
cannabis market while leveraging Spectrum Therapeutics' global
expertise in patient and physician education.
"Continuing to invest in training and education programs remains
a priority for us as a gap in knowledge still exists for many
healthcare professionals when it comes to medical cannabis,"
comments Dr. Mark Ware, Chief
Medical Officer, Canopy Growth. "By partnering with Tree of
Knowledge we're able to deliver these initiatives at scale which
will provide more patients with access to knowledge on the
potential of cannabis to address their needs with the guidance of a
doctor."
Spectrum Therapeutics and Tree of Knowledge will also work
together on patient education including an animated video series
and a customized patient dosing diary. Education programs will
focus on topics like multidisciplinary pain management and opioid
reduction programs.
"The need for patient and provider cannabis education has grown
substantially since legalization one year ago," said Michael Caridi, Chairman of Tree of Knowledge.
"This strategic partnership with a global leader like Spectrum
Therapeutics places focus squarely on educating patients in a
medical setting. This partnership will launch targeted
educational campaigns for patients in addition to providing
training and support to their health care providers."
About Canopy Growth Corporation
Canopy Growth
(TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp
and cannabis device company, offering distinct brands and curated
cannabis varieties in dried, oil and Softgel capsule forms, as well
as medical devices through Canopy Growth's subsidiary, Storz &
Bickel GMbH & Co. KG. From product and process innovation to
market execution, Canopy Growth is driven by a passion for
leadership and a commitment to building a world-class cannabis
company one product, site and country at a time. Canopy Growth has
operations in over a dozen countries across five continents.
Canopy Growth's medical division, Spectrum Therapeutics is
proudly dedicated to educating healthcare practitioners, conducting
robust clinical research, and furthering the public's understanding
of cannabis, and has devoted millions of dollars toward cutting
edge, commercializable research and IP development. Spectrum
Therapeutics sells a range of full-spectrum products using its
colour-coded classification Spectrum system as well as single
cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo
Smoke banners. Tweed is a globally recognized cannabis brand which
has built a large and loyal following by focusing on quality
products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange
and New York Stock Exchange to our continued international
expansion, pride in advancing shareholder value through leadership
is engrained in all we do at Canopy Growth. Canopy Growth has
established partnerships with leading sector names including
cannabis icons Snoop Dogg and Seth
Rogen, breeding legends DNA Genetics and Green House Seeds,
and Fortune 500 alcohol leader Constellation Brands, to name but a
few. Canopy Growth operates eleven licensed cannabis production
sites with over 10.5 million square feet of production capacity,
including over one million square feet of GMP certified production
space. For more information visit www.canopygrowth.com
About Spectrum Therapeutics
Spectrum Therapeutics, the
medical division of Canopy Growth Corporation (TSX: WEED, NYSE:
CGC), is dedicated to educating healthcare practitioners,
furthering the public's understanding of medical cannabis and its
various applications, and cutting edge, commercializable research
and IP development. Founded in Canada, Spectrum Therapeutics operates in
Australia, South America, Africa and across Europe. Its products are available in a wide
range of potencies and formats designed to simplify the dialogue
around strength and dosage by applying a colour-coded spectrum to
categorize medical cannabis according to THC and CBD levels.
Spectrum Therapeutics' offerings include whole flower cannabis,
oils and new innovations such as Softgels in addition to single
cannabinoid medicine Dronabinol under the brand Bionorica Ethics.
Through product simplification, robust clinical research and
ongoing education of healthcare professionals, Spectrum
Therapeutics is committed to addressing the unmet medical needs of
patients around the globe.
About Tree of Knowledge
With its head office in
Toronto, and operations in
North York, Ontario and
Spokane, Washington, TOKI
currently has three primary business segments: (1)
Multidisciplinary specialty pain clinics with a focus on the
treatment of chronic pain, including controlled applications of
medical cannabis in Canada, (2)
Development of formulated products for therapeutic purposes and
natural health product alternatives at its manufacturing facility
in Spokane, which provides
formulations for the Company's products and for third parties
equivalent to GMP standards, and (3) Distribution and sale of
hemp-based cannabidiol ("CBD") products in the United States, Canada, Europe, Brazil and Australia. Through its Toronto Poly Clinic,
the Company has gleaned extensive expertise from being involved in
one of the largest observational clinical trials on medical
cannabis and from its ongoing direct patient experience. The
Company has developed and implemented MCERP (Medical Cannabis
Education, Research and Best Practice Platform) and MCORP (Medical
Cannabis Opioid Reduction Program) with great success. Currently,
the Company has research agreements with multiple universities for
medical cannabis research and new medical grade products
development. TOKI's CBD product line contains EVR Premium Hemp Oil,
which is an organically grown and handled, gluten-free, vegan,
non-GMO, synergistic compound that is derived from U.S. Department
of Agriculture (USDA) approved industrial hemp grown in
the United States. TOKI currently
offers several CBD products, which may be used in connection with
the treatment of a number of ailments and for general wellness
purposes. https://www.tokicorp.com/
About Jack Nathan Health®
Jack Nathan
Health® is a privately owned and operated Canadian company—and a
proud partner of Walmart Canada—dedicated to improving access to
healthcare by partnering with highly-qualified medical
professionals and delivering consistent, easy-access,
patient-centric quality care in state-of-the-art medical and dental
clinics conveniently located inside Walmart Supercenters, with
70-plus locations across Canada.
Clinics are independently owned and operated under license by Jack
Nathan Medical Inc., and not affiliated with Walmart. Jack
Nathan Health® is a registered trade-mark of Jack Nathan Medical
Inc. All representations contained herein are made solely by Jack
Nathan Health® or its licensed owner operators, and not
independently verified by Walmart. All Walmart trademarks are the
property of Wal-Mart Stores, Inc. and are used under license.
For more information, virtual clinic tours, and social media links,
visit www.jacknathanhealth.com.
Notice Regarding Forward Looking Statements
This news
release contains "forward-looking statements" within the meaning of
the United States Private Securities Litigation Reform Act of 1995
and "forward-looking information" within the meaning of applicable
Canadian securities legislation. Often, but not always,
forward-looking statements and information can be identified by the
use of words such as "plans", "expects" or "does not expect", "is
expected", "estimates", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements or information involve known and unknown
risks, uncertainties and other factors which may cause the actual
results, performance or achievements of Canopy Growth or its
subsidiaries to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements or information contained in this news
release. Examples of such statements include "will host live
webinars presented by leading Canadian experts on medical cannabis"
and "will also work together on patient education including an
animated video series and a customized patient dosing diary".
Risks, uncertainties and other factors involved with
forward-looking information could cause actual events, results,
performance, prospects and opportunities to differ materially from
those expressed or implied by such forward-looking information,
including the development and delivery of educational content, and
such risks contained in the Company's annual information form dated
June 25, 2019 and filed with Canadian
securities regulators available on the Company's issuer profile on
SEDAR at www.sedar.com. Although the Company believes that the
assumptions and factors used in preparing the forward-looking
information or forward-looking statements in this news release are
reasonable, undue reliance should not be placed on such information
and no assurance can be given that such events will occur in the
disclosed time frames or at all. The forward-looking information
and forward-looking statements included in this news release are
made as of the date of this news release and the Company does not
undertake an obligation to publicly update such forward-looking
information or forward-looking information to reflect new
information, subsequent events or otherwise unless required by
applicable securities laws.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/spectrum-therapeutics-and-tree-of-knowledge-announce-partnership-to-educate-and-support-healthcare-professionals-300947779.html
SOURCE Spectrum Therapeutics